Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics

NCT02951702 is registered in ClinicalTrials.gov with St. Luke's Hospital, Chesterfield, Missouri as lead sponsor.

NCT NCT02951702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02951702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
Lead sponsor
St. Luke's Hospital, Chesterfield, Missouri
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2016
Completion date
July 31, 2017
Enrollment
51 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection, prophylaxis, vancomycin